Short answer
Beauty Health Co (SKIN) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Fiscal quarter ended September 30, 2026 results announced November 5, 2026.
Beauty Health Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended September 30, 2026 results announced November 5, 2026
- Investor conference call scheduled to discuss quarterly financial performance
- Non-GAAP metrics included, with GAAP reconciliations in Exhibit 99.1
- Investors should review Exhibit 99.1 for the actual financial results and management commentary
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $69.2M, down 2.1%, as delivery-system sales fell to $18.8M from $20.8M
- Consumables returned to growth, reaching $50.4M versus $49.8M, supporting the 37,342-system active install base
- Adjusted EBITDA rose to $13.4M from $8.9M, with margin expanding to 19.3% from 12.6%
- Net loss narrowed to $0.9M from $11.0M, driven by lower operating expenses and higher gross margin
- $103.2M of 2026 Notes repaid, reducing cash to $112.4M from $232.7M at year-end 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Beauty Health Co 8-K filings
Get the next SKIN 8-K as it lands
Follow SKIN for push alerts, or ask the research agent what this filing means.